Expression	O
of	O
Th1	B-protein
and	I-protein
Th2	I-protein
type	I-protein
cytokines	I-protein
responding	O
to	O
HBsAg	B-protein
and	O
HBxAg	B-protein
in	O
chronic	O
hepatitis	O
B	O
patients	O
.	O

The	O
cytokine	B-protein
pattern	I-protein
on	O
viral	O
antigen	O
recognition	O
is	O
believed	O
to	O
exert	O
a	O
profound	O
influence	O
on	O
the	O
resolution	O
of	O
viral	O
infections	O
and	O
viral	O
clearance	O
.	O

This	O
study	O
was	O
initiated	O
to	O
investigate	O
whether	O
a	O
cytokine	B-protein
imbalance	O
oriented	O
toward	O
Th2	O
type	O
response	O
plays	O
a	O
role	O
in	O
chronic	O
hepatitis	O
B	O
.	O

Cytokine	B-protein
profiles	I-protein
of	O
peripheral	B-cell_type
blood	I-cell_type
mononuclear	I-cell_type
cells	I-cell_type
associated	O
with	O
chronic	O
hepatitis	O
B	O
were	O
analysed	O
by	O
RT-PCR	O
.	O

Upon	O
HBsAg	B-protein
stimulation	O
,	O
expression	O
of	O
IFN-gamma	B-protein
,	O
IL-2	B-protein
,	O
IL-4	B-protein
,	O
and	O
IL-10	B-protein
was	O
detected	O
in	O
41	O
%	O
,	O
8	O
%	O
,	O
41	O
%	O
,	O
and	O
50	O
%	O
of	O
the	O
patients	O
,	O
respectively	O
.	O

Among	O
these	O
cytokines	B-protein
,	O
the	O
expression	O
of	O
IFN-gamma	B-protein
was	O
associated	O
with	O
high	O
levels	O
of	O
serum	B-protein
AST/ALT	I-protein
.	O

However	O
,	O
we	O
could	O
not	O
prove	O
that	O
Th2	B-protein
type	I-protein
cytokines	I-protein
had	O
a	O
protective	O
effect	O
on	O
hepatocytes	B-cell_type
.	O

Upon	O
HBxAg	B-protein
stimulation	O
,	O
there	O
was	O
no	O
recognizable	O
association	O
of	O
cytokine	B-protein
patterns	I-protein
with	O
AST/ALT	O
levels	O
.	O

In	O
conclusion	O
,	O
production	O
of	O
a	O
Th1	B-protein
cytokine	I-protein
,	O
IFN-gamma	B-protein
,	O
by	O
HBsAg	B-protein
-reactive	O
cells	O
was	O
associated	O
with	O
hepatocyte	O
damage	O
in	O
chronic	O
hepatitis	O
B	O
,	O
while	O
no	O
counteracting	O
effect	O
of	O
Th2	B-protein
cytokines	I-protein
produced	O
by	O
those	O
cells	O
was	O
observed	O
.	O

J	NULL
Korean	NULL
Med	NULL
Sci	NULL
1999	NULL
;	NULL
14	NULL
:	NULL
175-81	NULL
ISSN	NULL
1011-8934	NULL
Copyright	NULL
Â©	NULL
The	NULL
Korean	NULL
Academy	NULL
of	NULL
Medical	NULL
Sciences	NULL
Expression	NULL
of	NULL
Thi	NULL
and	NULL
Th2	NULL
Type	NULL
Cytokines	NULL
Responding	NULL
to	NULL
HBsAg	NULL
and	NULL
HBxAg	NULL
in	NULL
Chronic	NULL
Hepatitis	NULL
B	NULL
Patients	NULL
The	NULL
cytokine	NULL
pattern	NULL
on	NULL
viral	NULL
antigen	NULL
recognition	NULL
is	NULL
believed	NULL
to	NULL
exert	NULL
a	NULL
profound	NULL
influence	NULL
on	NULL
the	NULL
resolution	NULL
of	NULL
viral	NULL
infections	NULL
and	NULL
viral	NULL
clearance	NULL
.	NULL

This	NULL
study	NULL
was	NULL
initiated	NULL
to	NULL
investigate	NULL
whether	NULL
a	NULL
cytokine	NULL
imbalance	NULL
oriented	NULL
toward	NULL
Th2	NULL
type	NULL
response	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B.	NULL
Cytokine	NULL
profiles	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
associated	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B	NULL
were	NULL
analysed	NULL
by	NULL
RT-PCR	NULL
.	NULL

Upon	NULL
HBsAg	NULL
stimulation	NULL
,	NULL
expression	NULL
of	NULL
IFN-7	NULL
,	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-10	NULL
was	NULL
detected	NULL
in	NULL
41	NULL
%	NULL
,	NULL
8	NULL
%	NULL
,	NULL
41	NULL
%	NULL
,	NULL
and	NULL
50	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
,	NULL
respectively	NULL
.	NULL

Among	NULL
these	NULL
cytokines	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
IFN-7	NULL
was	NULL
associated	NULL
with	NULL
high	NULL
levels	NULL
of	NULL
serum	NULL
AST/ALT	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
not	NULL
prove	NULL
that	NULL
Th2	NULL
type	NULL
cytokines	NULL
had	NULL
a	NULL
protective	NULL
effect	NULL
on	NULL
hepatocytes	NULL
.	NULL

Upon	NULL
HBxAg	NULL
stimulation	NULL
,	NULL
there	NULL
was	NULL
no	NULL
recognizable	NULL
association	NULL
of	NULL
cytokine	NULL
patterns	NULL
with	NULL
AST/ALT	NULL
levels	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
production	NULL
of	NULL
a	NULL
Th1	NULL
cytokine	NULL
,	NULL
IFN-7	NULL
,	NULL
by	NULL
HBsAg-reactive	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
hepatocyte	NULL
damage	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
,	NULL
while	NULL
no	NULL
counteracting	NULL
effect	NULL
of	NULL
Th2	NULL
Millina	NULL
Lee	NULL
,	NULL
MyungAe	NULL
Lee	NULL
,	NULL
Sung	NULL
Ki	NULL
Lee*	NULL
,	NULL
Minsik	NULL
Son	NULL
,	NULL
Sung-Won	NULL
Cho	NULL
'	NULL
,	NULL
Sun	NULL
Park	NULL
,	NULL
Hyung-l1	NULL
Kim	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
'Department	NULL
of	NULL
Gastroenterology	NULL
,	NULL
Ajou	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Suwon	NULL
,	NULL
Korea	NULL
*Department	NULL
of	NULL
Obstetrics	NULL
and	NULL
Gynecology	NULL
,	NULL
Konkuk	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
Received	NULL
:	NULL
4	NULL
September	NULL
1998	NULL
Accepted	NULL
:	NULL
31	NULL
October	NULL
1998	NULL
Address	NULL
for	NULL
correspondence	NULL
cytokines	NULL
produced	NULL
by	NULL
those	NULL
cells	NULL
was	NULL
observed	NULL
.	NULL

Key	NULL
Words	NULL
:	NULL
Hepatitis	NULL
B	NULL
virus	NULL
;	NULL
Hepatitis	NULL
B	NULL
surface	NULL
antigen	NULL
;	NULL
Cytokines	NULL
;	NULL
Hepatitis	NULL
B	NULL
,	NULL
chronic	NULL
INTRODUCTION	NULL
Chronic	NULL
infection	NULL
with	NULL
hepatitis	NULL
B	NULL
virus	NULL
(	NULL
HBV	NULL
)	NULL
is	NULL
the	NULL
primary	NULL
source	NULL
of	NULL
chronic	NULL
hepatitis	NULL
,	NULL
liver	NULL
cirrhosis	NULL
,	NULL
and	NULL
hepatocellular	NULL
carcinoma	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Since	NULL
HBV	NULL
is	NULL
a	NULL
noncytopathic	NULL
virus	NULL
,	NULL
cell-mediated	NULL
immunity	NULL
(	NULL
CMT	NULL
)	NULL
appears	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
elimination	NULL
of	NULL
HBV-infected	NULL
hepatocytes	NULL
and	NULL
viral	NULL
clearance	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Actually	NULL
,	NULL
patients	NULL
with	NULL
acute	NULL
hepatitis	NULL
B	NULL
are	NULL
able	NULL
to	NULL
produce	NULL
vigorous	NULL
proliferative	NULL
responses	NULL
of	NULL
T	NULL
cells	NULL
against	NULL
various	NULL
HBV	NULL
antigens	NULL
,	NULL
whereas	NULL
patients	NULL
with	NULL
chronic	NULL
HBV	NULL
infection	NULL
show	NULL
very	NULL
weak	NULL
T	NULL
cell	NULL
responses	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

HBV	NULL
genome	NULL
contains	NULL
four	NULL
open	NULL
reading	NULL
frames	NULL
encoding	NULL
HBsAg	NULL
,	NULL
HBc/eAg	NULL
,	NULL
polymerase	NULL
,	NULL
and	NULL
HBxAg	NULL
.	NULL

Immune	NULL
response	NULL
against	NULL
each	NULL
HBV	NULL
antigen	NULL
may	NULL
be	NULL
different	NULL
quan-titatively	NULL
and	NULL
possibly	NULL
qualitatively	NULL
.	NULL

Proliferative	NULL
responses	NULL
of	NULL
T	NULL
cells	NULL
against	NULL
HBc/eAg	NULL
are	NULL
readily	NULL
observed	NULL
in	NULL
patients	NULL
with	NULL
acute	NULL
hepatitis	NULL
B	NULL
and	NULL
during	NULL
the	NULL
acute	NULL
exacerbation	NULL
period	NULL
of	NULL
chronic	NULL
active	NULL
hepatitis	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
T	NULL
cell	NULL
responses	NULL
against	NULL
HBsAg	NULL
,	NULL
which	NULL
may	NULL
be	NULL
important	NULL
in	NULL
protective	NULL
immunity	NULL
against	NULL
HBV	NULL
infection	NULL
,	NULL
are	NULL
hardly	NULL
detectable	NULL
in	NULL
both	NULL
acute	NULL
and	NULL
chronic	NULL
hepatitis	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Immune	NULL
responses	NULL
against	NULL
polymerase	NULL
and	NULL
HBxAg	NULL
are	NULL
not	NULL
well	NULL
characterized	NULL
yet	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
mechanisms	NULL
of	NULL
how	NULL
HBV	NULL
escapes	NULL
immuno-	NULL
175	NULL
Millina	NULL
Lee	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Ph.D.	NULL
Department	NULL
of	NULL
Microbiology	NULL
,	NULL
Ajou	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
5	NULL
Wonchon-dong	NULL
,	NULL
Paldal-Ku	NULL
,	NULL
Suwon	NULL
442-749	NULL
,	NULL
Korea	NULL
Tel	NULL
:	NULL
+82.331-219-5074	NULL
,	NULL
Fax	NULL
:	NULL
+82.331-219-5079	NULL
E-mail	NULL
:	NULL
millina	NULL
@	NULL
madang.ajou.ac.kr	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Korean	NULL
Ministry	NULL
of	NULL
Education	NULL
(	NULL
97-	NULL
#	NULL
97	NULL
)	NULL
.	NULL

logic	NULL
surveillance	NULL
and	NULL
persists	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
remain	NULL
unclear	NULL
,	NULL
recent	NULL
studies	NULL
on	NULL
the	NULL
immunoregulation	NULL
in	NULL
microbial	NULL
infections	NULL
suggest	NULL
that	NULL
balances	NULL
in	NULL
cytokine	NULL
production	NULL
profiles	NULL
may	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
resolution	NULL
or	NULL
persistence	NULL
of	NULL
infection	NULL
(	NULL
9-11	NULL
)	NULL
.	NULL

Thl	NULL
type	NULL
cytokines	NULL
(	NULL
IFN-Y	NULL
and	NULL
IL-2	NULL
)	NULL
,	NULL
which	NULL
are	NULL
principally	NULL
involved	NULL
in	NULL
CMI	NULL
,	NULL
can	NULL
contribute	NULL
to	NULL
protection	NULL
from	NULL
viral	NULL
infections	NULL
,	NULL
while	NULL
predominant	NULL
Th2	NULL
type	NULL
cytokine	NULL
productions	NULL
(	NULL
IL-4	NULL
and	NULL
IL-10	NULL
)	NULL
may	NULL
inhibit	NULL
anti-viral	NULL
CMI	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
can	NULL
be	NULL
hypothesized	NULL
that	NULL
predominant	NULL
productions	NULL
of	NULL
Th2	NULL
type	NULL
cytokines	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
persistent	NULL
infection	NULL
with	NULL
HBV	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
cytokine	NULL
profile	NULL
associated	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMCs	NULL
)	NULL
obtained	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B	NULL
were	NULL
stimulated	NULL
with	NULL
HBsAg	NULL
or	NULL
HBxAg	NULL
and	NULL
tested	NULL
for	NULL
their	NULL
cytokine	NULL
expression	NULL
responses	NULL
to	NULL
antigen	NULL
stimulation	NULL
by	NULL
RT-PCR	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Patients	NULL
and	NULL
HBV	NULL
antigens	NULL
Subjects	NULL
studied	NULL
were	NULL
acute	NULL
and	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
attending	NULL
the	NULL
gastroenterology	NULL
services	NULL
of	NULL
Ajou	NULL
University	NULL
176	NULL
Medical	NULL
Center	NULL
.	NULL

In	NULL
chronic	NULL
hepatitis	NULL
patients	NULL
,	NULL
HBsAg	NULL
was	NULL
positive	NULL
for	NULL
longer	NULL
than	NULL
6	NULL
months	NULL
.	NULL

On	NULL
the	NULL
same	NULL
day	NULL
PBMCs	NULL
were	NULL
obtained	NULL
from	NULL
patients	NULL
,	NULL
serum	NULL
aspartate	NULL
transaminase	NULL
(	NULL
AST	NULL
)	NULL
and	NULL
alanine	NULL
transaminase	NULL
(	NULL
ALT	NULL
)	NULL
were	NULL
measured	NULL
.	NULL

Recombinant	NULL
yeast-derived	NULL
preparation	NULL
of	NULL
HBsAg	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
the	NULL
Green	NULL
Cross	NULL
Co	NULL
(	NULL
Seoul	NULL
,	NULL
Korea	NULL
)	NULL
.	NULL

HBxAg	NULL
was	NULL
prepared	NULL
by	NULL
expression	NULL
of	NULL
cloned	NULL
viral	NULL
DNA	NULL
in	NULL
E.	NULL
coli	NULL
using	NULL
the	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
gene	NULL
fusion	NULL
system	NULL
(	NULL
Pharmacia	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
pGEM-4T-1	NULL
carrying	NULL
HBx	NULL
open	NULL
reading	NULL
frame	NULL
(	NULL
pGEX-HBx	NULL
)	NULL
was	NULL
kindly	NULL
given	NULL
by	NULL
Dr.	NULL
W-K	NULL
Kim	NULL
,	NULL
Institute	NULL
for	NULL
Medical	NULL
Sci-ence	NULL
,	NULL
Ajou	NULL
University	NULL
,	NULL
Suwon	NULL
,	NULL
Korea	NULL
.	NULL

For	NULL
the	NULL
expression	NULL
of	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
,	NULL
the	NULL
plasmid	NULL
was	NULL
transformed	NULL
in	NULL
E.	NULL
coli	NULL
cells	NULL
BL21	NULL
.	NULL

After	NULL
cultivating	NULL
the	NULL
transformed	NULL
BL21	NULL
in	NULL
LB	NULL
medium	NULL
containing	NULL
ampicillin	NULL
until	NULL
the	NULL
ODe	NULL
reached	NULL
around	NULL
0.6	NULL
,	NULL
expression	NULL
was	NULL
induced	NULL
by	NULL
0.1	NULL
mM	NULL
IPTG	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
5-6	NULL
hr	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
at	NULL
6,000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
Tris-HCl	NULL
buffer	NULL
solution	NULL
(	NULL
pH	NULL
7.4	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
the	NULL
Tris-HCI	NULL
buffer	NULL
solution	NULL
containing	NULL
0.5	NULL
%	NULL
NP-40	NULL
,	NULL
sonicated	NULL
(	NULL
Heat	NULL
system	NULL
Inc.	NULL
,	NULL
U.S.A.	NULL
)	NULL
for	NULL
2	NULL
min	NULL
,	NULL
cooled	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
spun	NULL
down	NULL
at	NULL
10,000	NULL
g	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Soluble	NULL
cell	NULL
extract	NULL
was	NULL
collected	NULL
and	NULL
filtered	NULL
with	NULL
a	NULL
0.45	NULL
um	NULL
filter	NULL
.	NULL

The	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
by	NULL
Glutathione	NULL
Sepharose	NULL
4B	NULL
affinity	NULL
chromatography	NULL
(	NULL
Pharmacia	NULL
,	NULL
Sweden	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cell	NULL
extract	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
Glutathione	NULL
Sepharose	NULL
4B	NULL
column	NULL
.	NULL

The	NULL
column	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
10	NULL
bed	NULL
volume	NULL
of	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
and	NULL
the	NULL
fusion	NULL
protein	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
glutathione	NULL
elution	NULL
buffer	NULL
(	NULL
pH	NULL
8.5	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
and	NULL
10	NULL
mM	NULL
reduced	NULL
glutathione	NULL
)	NULL
.	NULL

The	NULL
eluate	NULL
was	NULL
concentrated	NULL
using	NULL
a	NULL
ultrafiltrator	NULL
(	NULL
Amicon	NULL
Inc.	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
further	NULL
purified	NULL
by	NULL
Sephacryl	NULL
S-100	NULL
gel	NULL
filtration	NULL
to	NULL
use	NULL
as	NULL
an	NULL
antigen	NULL
.	NULL

Culture	NULL
medium	NULL
The	NULL
culture	NULL
medium	NULL
used	NULL
was	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
50	NULL
uM	NULL
2-mercaptoethanol	NULL
,	NULL
10mM	NULL
HEPES	NULL
,	NULL
100	NULL
U/mL	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
streptomycin	NULL
(	NULL
all	NULL
from	NULL
GIBCOBRL	NULL
Lab	NULL
.	NULL

,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
and	NULL
10	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Â¢hIL-2	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
PBMCs	NULL
were	NULL
separated	NULL
from	NULL
fresh	NULL
heparinized	NULL
blood	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Using	NULL
24	NULL
well	NULL
culture	NULL
plates	NULL
(	NULL
Costar	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
PBMCs	NULL
(	NULL
1	NULL
X	NULL
10Â¢/well	NULL
)	NULL
in	NULL
the	NULL
complete	NULL
medium	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
HBsAg	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
for	NULL
7	NULL
days	NULL
at	NULL
37Â°C	NULL
in	NULL
a	NULL
humidified	NULL
5	NULL
%	NULL
CO	NULL
incubator	NULL
.	NULL

Then	NULL
HBsAg-reactive	NULL
cells	NULL
were	NULL
preferentially	NULL
expanded	NULL
for	NULL
7	NULL
days	NULL
by	NULL
adding	NULL
rhIL-2	NULL
(	NULL
10	NULL
U/mL	NULL
)	NULL
.	NULL

M.	NULL
Lee	NULL
,	NULL
M.A	NULL
.	NULL

Lee	NULL
,	NULL
S.K	NULL
.	NULL

Lee	NULL
,	NULL
et	NULL
al	NULL
.	NULL

For	NULL
cytokine	NULL
assays	NULL
,	NULL
the	NULL
HBsAg-reactive	NULL
cell	NULL
populations	NULL
(	NULL
1	NULL
X	NULL
10Â°/mL	NULL
)	NULL
was	NULL
restimulated	NULL
with	NULL
HBsAg	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
irradiated	NULL
(	NULL
3,000	NULL
Rad	NULL
;	NULL
gamma	NULL
cell	NULL
3000	NULL
Elan	NULL
;	NULL
Nordion	NULL
,	NULL
Kanata	NULL
,	NULL
Ontario	NULL
)	NULL
autologous	NULL
PBMCs	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
/mL	NULL
)	NULL
as	NULL
feed-er/antigen	NULL
presenting	NULL
cells	NULL
.	NULL

Supernatants	NULL
of	NULL
the	NULL
antigen-stimulated	NULL
and	NULL
control	NULL
cultures	NULL
were	NULL
collected	NULL
after	NULL
4	NULL
days	NULL
and	NULL
human	NULL
cytokine	NULL
ELISA	NULL
kits	NULL
(	NULL
Endogen	NULL
,	NULL
Woburn	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
used	NULL
for	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
.	NULL

Cytokine	NULL
RT-PCR	NULL
PBMCs	NULL
(	NULL
1	NULL
X	NULL
10Â®/mL	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
HBsAg	NULL
(	NULL
5	NULL
ug/ml	NULL
)	NULL
.	NULL

After	NULL
12	NULL
hr	NULL
,	NULL
24	NULL
hr	NULL
and	NULL
72	NULL
hr	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
a	NULL
semi-quantitative	NULL
cytokine	NULL
RT-PCR	NULL
.	NULL

Antigen-stimulated	NULL
PBMCs	NULL
were	NULL
harvested	NULL
for	NULL
total	NULL
RNA	NULL
extraction	NULL
with	NULL
acid	NULL
guanidinium	NULL
thio-cyanate-phenol-chloroform	NULL
and	NULL
isopropanol	NULL
precipitation	NULL
.	NULL

Vacuum-dried	NULL
pellets	NULL
were	NULL
dissolved	NULL
in	NULL
15	NULL
ul	NULL
DEPC-treat-ed-distilled	NULL
water	NULL
and	NULL
incubated	NULL
for	NULL
65Â°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

After	NULL
cooling	NULL
on	NULL
ice	NULL
,	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37	NULL
Â°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
wL	NULL
of	NULL
2	NULL
x	NULL
reverse	NULL
transcriptase	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH	NULL
8.3	NULL
,	NULL
150	NULL
mM	NULL
KCI	NULL
,	NULL
6	NULL
mM	NULL
MgCl	NULL
Â»	NULL
,	NULL
20	NULL
mM	NULL
DTT	NULL
)	NULL
,	NULL
0.5	NULL
ug	NULL
oligo-dT	NULL
(	NULL
18-mer	NULL
;	NULL
Amitof	NULL
Co.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
,	NULL
final	NULL
concentrations	NULL
of	NULL
200	NULL
units	NULL
of	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Superscript	NULL
IITM	NULL
,	NULL
Gibco	NULL
BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
0.5	NULL
mM	NULL
dNTP	NULL
,	NULL
and	NULL
25	NULL
U	NULL
of	NULL
RNasin	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WJ	NULL
)	NULL
.	NULL

Tubes	NULL
were	NULL
then	NULL
heated	NULL
to	NULL
95Â°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
130	NULL
ul	NULL
of	NULL
distilled	NULL
water	NULL
was	NULL
added	NULL
to	NULL
the	NULL
20	NULL
ul	NULL
reaction	NULL
mixture	NULL
.	NULL

Samples	NULL
were	NULL
stored	NULL
at	NULL
-20Â°C	NULL
until	NULL
further	NULL
use	NULL
.	NULL

Sequences	NULL
of	NULL
cytokine-specific	NULL
primer	NULL
pairs	NULL
,	NULL
designed	NULL
to	NULL
be	NULL
complementary	NULL
to	NULL
the	NULL
sequences	NULL
in	NULL
different	NULL
exons	NULL
,	NULL
and	NULL
probes	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
IL-2	NULL
senseprimer	NULL
:	NULL
5-CCTCA	NULL
ACTCCTGCCACAATG-3	NULL
IL-2	NULL
anti-sense	NULL
primer	NULL
:	NULL
5-TTGCTGATTAAGTCCCTGG	NULL
G-Â¥	NULL
(	NULL
340	NULL
bps	NULL
)	NULL
,	NULL
IL-2	NULL
probe	NULL
:	NULL
9-TACATGCC	NULL
CAAGAAGGCCACAGAACTGA	NULL
AA-Â¥	NULL
,	NULL
IEN-	NULL
?	NULL

-	NULL
sense	NULL
primer	NULL
:	NULL
5-TCGTTTTGGGTTCTCITGGC-3	NULL
,	NULL
IFN-7	NULL
-	NULL
anti-sense	NULL
primer	NULL
:	NULL
5-GCAGGCAGGACAAC-CATTAC-3	NULL
'	NULL
(	NULL
477	NULL
bps	NULL
)	NULL
,	NULL
IFN-	NULL
Â»	NULL
probe	NULL
:	NULL
5Â°-CTGACTA	NULL
IL-4	NULL
sense	NULL
primer	NULL
:	NULL
5Â°-GCTTCCCCCTCT	NULL
GTTCTTCC-3	NULL
'	NULL
,	NULL
IL-4	NULL
anti-sense	NULL
primer	NULL
:	NULL
9-TCTGGTTGGCTTCCTTCACA-Â¥	NULL
'	NULL
(	NULL
371	NULL
bps	NULL
)	NULL
,	NULL
IL-4	NULL
probe	NULL
:	NULL
5-TTTGCTGCCTCCAAGAACACAACT-GAGAAG-3	NULL
'	NULL
,	NULL
IL-10	NULL
sense	NULL
primer	NULL
:	NULL
5-CTGAGAAC-CAAGACCCAGACATCAAGG-2	NULL
'	NULL
,	NULL
IL-10	NULL
anti-sense	NULL
primer	NULL
:	NULL
5	NULL
-CAATAAGGTTTCTCAAGGGGCTGG-Â¥	NULL
(	NULL
351	NULL
bps	NULL
)	NULL
,	NULL
IL-10	NULL
probe	NULL
:	NULL
5-AATGCCTTTAATAAGCTCCAAGA-GAAAGGC-3	NULL
``	NULL
,	NULL
GAPDH	NULL
sense	NULL
primer	NULL
:	NULL
5-GCAGGGGG	NULL
GAGCCAAAAGGG-3	NULL
'	NULL
GAPDH	NULL
anti-sense	NULL
primer	NULL
:	NULL
TGCCAGCCCCAGCGT	NULL
CAAAG-Â¥	NULL
(	NULL
567	NULL
bps	NULL
)	NULL
,	NULL
GAPDH	NULL
probe	NULL
:	NULL
5Â°-GTGGAAGGACTCATGACCACAGTC	NULL
CAT	NULL
GCC-2	NULL
'	NULL
.	NULL

Twenty-five	NULL
gl	NULL
,	NULL
of	NULL
each	NULL
cDNA	NULL
were	NULL
amplified	NULL
in	NULL
0.2	NULL
mL	NULL
MicroAmp	NULL
reaction	NULL
tubes	NULL
(	NULL
Perkin-Elmer	NULL
,	NULL
Branch-burg	NULL
,	NULL
NJ	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
200	NULL
uM	NULL
final	NULL
concentration	NULL
of	NULL
Cytokine	NULL
Profiles	NULL
Associated	NULL
with	NULL
Chronic	NULL
Hepatitis	NULL
B	NULL
primers	NULL
,	NULL
200	NULL
uM	NULL
dNTP	NULL
,	NULL
2.5	NULL
U	NULL
of	NULL
Teg	NULL
polymerase	NULL
(	NULL
Gibco	NULL
BRL	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
PCR	NULL
buffer	NULL
containing	NULL
1.5	NULL
mM	NULL
MgCl	NULL
Â»	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
pH8.4	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
50	NULL
ul	NULL
.	NULL

PCR	NULL
was	NULL
performed	NULL
in	NULL
a	NULL
thermal	NULL
cycler	NULL
(	NULL
Perkin	NULL
Elmer-Cetus	NULL
,	NULL
Emeryville	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
35	NULL
cycles	NULL
:	NULL
45	NULL
sec	NULL
denaturation	NULL
at	NULL
94Â°C	NULL
,	NULL
45	NULL
sec	NULL
annealing	NULL
at	NULL
52Â°C	NULL
,	NULL
and	NULL
45	NULL
sec	NULL
extension	NULL
at	NULL
72Â°C	NULL
.	NULL

After	NULL
amplification	NULL
,	NULL
10	NULL
ul	NULL
of	NULL
the	NULL
PCR	NULL
product	NULL
was	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
in	NULL
1.2	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
fragments	NULL
were	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
paper	NULL
.	NULL

The	NULL
authenticity	NULL
of	NULL
the	NULL
amplified	NULL
products	NULL
was	NULL
confirmed	NULL
by	NULL
Southern	NULL
blotting	NULL
and	NULL
hybridization	NULL
with	NULL
P-labeled	NULL
specific	NULL
oligonucleotide	NULL
probes	NULL
.	NULL

Size	NULL
of	NULL
the	NULL
amplified	NULL
target	NULL
sequences	NULL
was	NULL
validated	NULL
by	NULL
running	NULL
in	NULL
parallel	NULL
P-labeled	NULL
molecular	NULL
size	NULL
marker	NULL
.	NULL

A	NULL
relative	NULL
amount	NULL
of	NULL
each	NULL
cytokine	NULL
mRNA	NULL
to	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
phosphor	NULL
imaging	NULL
analyzer	NULL
(	NULL
BAS2500	NULL
,	NULL
Fuji	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

RESULTS	NULL
Production	NULL
of	NULL
IFN-	NULL
Â»	NULL
by	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
'To	NULL
investigate	NULL
whether	NULL
there	NULL
are	NULL
any	NULL
differences	NULL
in	NULL
cytokine	NULL
profiles	NULL
of	NULL
HBsAg-reactive	NULL
T	NULL
cells	NULL
between	NULL
acute	NULL
and	NULL
chronic	NULL
hepatitis	NULL
,	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
prepared	NULL
from	NULL
PBMCs	NULL
of	NULL
hepatitis	NULL
B	NULL
patients	NULL
and	NULL
analysed	NULL
for	NULL
their	NULL
production	NULL
of	NULL
IFN-7	NULL
-	NULL
and	NULL
IL-4	NULL
by	NULL
ELISA	NULL
.	NULL

Upon	NULL
stimulation	NULL
with	NULL
HBsAg	NULL
,	NULL
IFN-7	NULL
was	NULL
produced	NULL
in	NULL
80	NULL
%	NULL
of	NULL
the	NULL
acute	NULL
hepatitis	NULL
patients	NULL
.	NULL

Production	NULL
of	NULL
IFN-	NULL
Â»	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
25	NULL
%	NULL
of	NULL
the	NULL
chronic	NULL
hepatitis	NULL
patients	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
production	NULL
of	NULL
IL-4	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
any	NULL
patient	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Since	NULL
some	NULL
chronic	NULL
hepatitis	NULL
patients	NULL
showed	NULL
IFN-Â¥	NULL
produc-tion	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
examine	NULL
cytokine	NULL
profiles	NULL
associated	NULL
with	NULL
chronic	NULL
hepatitis	NULL
in	NULL
more	NULL
detail	NULL
using	NULL
RT-PCR	NULL
.	NULL

Cytokine	NULL
expression	NULL
profiles	NULL
of	NULL
PBMCs	NULL
upon	NULL
stimulation	NULL
with	NULL
HBsAg	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
For	NULL
further	NULL
investigation	NULL
on	NULL
cytokine	NULL
patterns	NULL
in	NULL
the	NULL
immune	NULL
response	NULL
against	NULL
HBsAg	NULL
during	NULL
chronic	NULL
HBV	NULL
infection	NULL
,	NULL
PBMCs	NULL
were	NULL
obtained	NULL
from	NULL
12	NULL
patients	NULL
showing	NULL
various	NULL
serum	NULL
levels	NULL
of	NULL
AST/ALT	NULL
,	NULL
and	NULL
analysed	NULL
for	NULL
their	NULL
produc-	NULL
Table	NULL
1	NULL
.	NULL

Cytokine	NULL
production	NULL
by	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
obtained	NULL
from	NULL
PBMCs	NULL
of	NULL
viral	NULL
hepatitis	NULL
B	NULL
patients	NULL
,	NULL
No	NULL
.	NULL

of	NULL
positive	NULL
T	NULL
cell	NULL
population	NULL
(	NULL
%	NULL
)	NULL
*	NULL
Groups	NULL
of	NULL
patients	NULL
IFN-y	NULL
IL-4	NULL
Acute	NULL
hepatitis	NULL
4/5	NULL
(	NULL
80	NULL
%	NULL
)	NULL
0/5	NULL
(	NULL
0	NULL
%	NULL
)	NULL
Chronic	NULL
hepatitis	NULL
2/8	NULL
(	NULL
25	NULL
%	NULL
)	NULL
0/8	NULL
(	NULL
0	NULL
%	NULL
)	NULL
*Production	NULL
of	NULL
cytokines	NULL
was	NULL
analysed	NULL
by	NULL
ELISA	NULL
after	NULL
stimulation	NULL
with	NULL
HBsAg	NULL
.	NULL

177	NULL
Patient	NULL
CH	NULL
3	NULL
Patient	NULL
CH	NULL
8	NULL
Patient	NULL
CH	NULL
9	NULL
HBs	NULL
Antigen	NULL
HBs	NULL
Antigen	NULL
HBs	NULL
Antigen	NULL
T	NULL
-	NULL
q	NULL
oC	NULL
-	NULL
qo	NULL
]	NULL
-	NULL
Â£	NULL
O	NULL
I	NULL
1	NULL
I	NULL
1	NULL
I	NULL
1	NULL
T	NULL
1	NULL
I	NULL
1	NULL
I	NULL
1	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
12	NULL
2472	NULL
12	NULL
2472	NULL
12	NULL
2472	NULL
12	NULL
2472	NULL
12	NULL
2472	NULL
12	NULL
2472	NULL
Lolc_	NULL
@	NULL
|	NULL
[	NULL
oo	NULL
cee	NULL
Gell	NULL
|	NULL
|	NULL
(	NULL
000/000	NULL
-	NULL
|	NULL
it-2	NULL
``	NULL
â	NULL
``	NULL
f	NULL
â	NULL
W	NULL
``	NULL
R	NULL
â	NULL
|	NULL
|	NULL
â	NULL
1M	NULL
l	NULL
Tl	NULL
|	NULL
;	NULL
,	NULL
.	NULL

,	NULL
=	NULL
@	NULL
--	NULL
]	NULL
Â«	NULL
-	NULL
|	NULL
@	NULL
@	NULL
saebe	NULL
|_-	NULL
wud	NULL
..	NULL
,	NULL
.	NULL

crcieee	NULL
ada==	NULL
Â«	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Expression	NULL
of	NULL
cytokine	NULL
mRNAs	NULL
in	NULL
PBMCs	NULL
of	NULL
chronic	NULL
hepati-	NULL
tis	NULL
B	NULL
patients	NULL
responding	NULL
to	NULL
HBsAg	NULL
stimulation	NULL
.	NULL

PBMCs	NULL
(	NULL
1	NULL
x	NULL
10Â¢/mL	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
HBsAg	NULL
(	NULL
5	NULL
ug/	NULL
mL	NULL
)	NULL
.	NULL

After	NULL
12	NULL
hr	NULL
,	NULL
24	NULL
hr	NULL
,	NULL
and	NULL
72	NULL
hr	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
sub	NULL
jected	NULL
to	NULL
semi-quantitative	NULL
RT-PCR	NULL
.	NULL

Representative	NULL
autoradiogram	NULL
results	NULL
are	NULL
shown	NULL
.	NULL

Table	NULL
2	NULL
.	NULL

Cytokine	NULL
expression	NULL
prefiles	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
HBsAg	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
:	NULL
AST/ALT	NULL
IL-10	NULL
__	NULL
IL-4	NULL
IL-2	NULL
_	NULL
IFN-7	NULL
Patients	NULL
(	NULL
U/mL	NULL
CH	NULL
1	NULL
32/44	NULL
-	NULL
-	NULL
-	NULL
CH	NULL
2	NULL
74/143	NULL
+	NULL
+	NULL
-*	NULL
+	NULL
CH	NULL
3	NULL
97/152	NULL
+	NULL
+	NULL
-	NULL
CH	NULL
4	NULL
156/845	NULL
+	NULL
CH	NULL
5	NULL
199/220	NULL
-	NULL
+	NULL
CH	NULL
6	NULL
440/1090	NULL
-	NULL
CH	NULL
7	NULL
470/1140	NULL
-	NULL
-	NULL
CH	NULL
8	NULL
533/402	NULL
+	NULL
-	NULL
+	NULL
CH	NULL
9	NULL
550/860	NULL
+	NULL
-	NULL
-*	NULL
+	NULL
CH10	NULL
590/1490	NULL
+	NULL
+	NULL
-*	NULL
+	NULL
CH11	NULL
941/1150	NULL
-	NULL
-	NULL
-	NULL
+	NULL
CH12	NULL
1462/1500	NULL
+	NULL
+	NULL
+	NULL
Cytokine	NULL
expression	NULL
levels	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
HBsAg	NULL
were	NULL
compared	NULL
with	NULL
levels	NULL
of	NULL
unstimulated	NULL
PBMCs	NULL
.	NULL

-	NULL
:	NULL
no	NULL
difference	NULL
,	NULL
+	NULL
:	NULL
increased	NULL
,	NULL
-*	NULL
:	NULL
not	NULL
detectable	NULL
tion	NULL
of	NULL
IL-10	NULL
,	NULL
IL-4	NULL
,	NULL
IL-2	NULL
and	NULL
INF-7	NULL
by	NULL
RT-PCR	NULL
.	NULL

Expression	NULL
of	NULL
each	NULL
cytokine	NULL
was	NULL
assessed	NULL
at	NULL
the	NULL
time	NULL
of	NULL
12	NULL
hr	NULL
,	NULL
24	NULL
hr	NULL
,	NULL
and	NULL
72	NULL
hr	NULL
incubation	NULL
.	NULL

Age	NULL
of	NULL
the	NULL
patients	NULL
was	NULL
34	NULL
+11	NULL
years	NULL
old	NULL
and	NULL
all	NULL
patients	NULL
were	NULL
male	NULL
except	NULL
one	NULL
female	NULL
patient	NULL
.	NULL

Various	NULL
patterns	NULL
of	NULL
the	NULL
cytokine	NULL
expression	NULL
were	NULL
observed	NULL
depending	NULL
on	NULL
the	NULL
individuals	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
patient	NULL
CH	NULL
showed	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
Th2	NULL
type	NULL
cytokine	NULL
(	NULL
IL-4	NULL
)	NULL
,	NULL
while	NULL
patient	NULL
CH	NULL
showed	NULL
increased	NULL
expressions	NULL
of	NULL
both	NULL
Thl	NULL
type	NULL
cytokine	NULL
(	NULL
IFN-y	NULL
)	NULL
and	NULL
Th2	NULL
type	NULL
cytokine	NULL
(	NULL
IL-10	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Patient	NULL
CHS	NULL
was	NULL
the	NULL
only	NULL
patient	NULL
who	NULL
showed	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
IL-2	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

2	NULL
shows	NULL
example	NULL
of	NULL
results	NULL
analysed	NULL
by	NULL
a	NULL
phosphor	NULL
imaging	NULL
analyzer	NULL
.	NULL

As	NULL
Table	NULL
2	NULL
shows	NULL
,	NULL
about	NULL
75	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
showed	NULL
178	NULL
M.	NULL
Lee	NULL
,	NULL
M.A	NULL
.	NULL

Lee	NULL
,	NULL
S.K	NULL
.	NULL

Lee	NULL
,	NULL
et	NULL
al	NULL
.	NULL

5	NULL
7	NULL
IL-10	NULL
5	NULL
-	NULL
IL-4	NULL
5	NULL
-	NULL
IL-2	NULL
4	NULL
-	NULL
4	NULL
-	NULL
4	NULL
3	NULL
-	NULL
3	NULL
-	NULL
3	NULL
2	NULL
-	NULL
2	NULL
-	NULL
2	NULL
1	NULL
-	NULL
17	NULL
17	NULL
<	NULL
_	NULL
_	NULL
_	NULL
Z	NULL
%	NULL
0	NULL
T	NULL
T	NULL
T	NULL
1	NULL
0	NULL
T	NULL
T	NULL
T	NULL
1	NULL
0	NULL
T	NULL
T	NULL
T	NULL
1	NULL
E	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
C	NULL
3	NULL
Time	NULL
in	NULL
Cultivation	NULL
(	NULL
hr	NULL
)	NULL
Time	NULL
in	NULL
Cultivation	NULL
(	NULL
hr	NULL
)	NULL
Time	NULL
in	NULL
Cultivation	NULL
(	NULL
hr	NULL
)	NULL
Â£	NULL
$	NULL
s-	NULL
IFN-	NULL
Â»	NULL
Â©	NULL
=	NULL
|	NULL
O	NULL
&	NULL
C	NULL
4	NULL
_	NULL
3	NULL
-I	NULL
2	NULL
_	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Cytokine	NULL
expressions	NULL
of	NULL
PBMCs	NULL
obtained	NULL
from	NULL
a	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patient	NULL
q	NULL
-	NULL
(	NULL
CH3	NULL
)	NULL
.	NULL

PBMCs	NULL
were	NULL
cultivated	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
@	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
0	NULL
)	NULL
of	NULL
HBsAg	NULL
.	NULL

After	NULL
12	NULL
,	NULL
|	NULL
24	NULL
,	NULL
and	NULL
72	NULL
hr	NULL
of	NULL
cultivation	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
and	NULL
South-em	NULL
blot	NULL
hybridization	NULL
.	NULL

A	NULL
relative	NULL
amount	NULL
of	NULL
each	NULL
cytokine	NULL
mRNA	NULL
to	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
0	NULL
0	NULL
2	NULL
'	NULL
0	NULL
4	NULL
'	NULL
0	NULL
6	NULL
'	NULL
0	NULL
8	NULL
'	NULL
0	NULL
quantitated	NULL
using	NULL
a	NULL
phosphor	NULL
imaging	NULL
analyzer	NULL
.	NULL

Time	NULL
in	NULL
Cultivation	NULL
(	NULL
hr	NULL
)	NULL
cytokine	NULL
production	NULL
responses	NULL
upon	NULL
HBsAg	NULL
stimulation	NULL
.	NULL

Depending	NULL
on	NULL
cytokine	NULL
patterns	NULL
,	NULL
the	NULL
patients	NULL
could	NULL
be	NULL
divided	NULL
into	NULL
three	NULL
groups	NULL
:	NULL
production	NULL
of	NULL
Th2	NULL
type	NULL
alone	NULL
was	NULL
observed	NULL
in	NULL
25	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
,	NULL
both	NULL
Th2	NULL
and	NULL
Thl	NULL
type	NULL
was	NULL
42	NULL
%	NULL
,	NULL
and	NULL
Thl	NULL
type	NULL
alone	NULL
was	NULL
8	NULL
%	NULL
.	NULL

While	NULL
each	NULL
cytokine	NULL
expression	NULL
of	NULL
IL-10	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
INFE-	NULL
?	NULL

was	NULL
observed	NULL
in	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
,	NULL
IL-2	NULL
expression	NULL
was	NULL
observed	NULL
only	NULL
in	NULL
one	NULL
patient	NULL
(	NULL
8	NULL
%	NULL
)	NULL
.	NULL

This	NULL
result	NULL
was	NULL
consistent	NULL
with	NULL
poor	NULL
proliferative	NULL
responses	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
HBsAg	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Relationship	NULL
between	NULL
expression	NULL
of	NULL
INF-y	NULL
in	NULL
response	NULL
to	NULL
HBsAg	NULL
and	NULL
hepatocyte	NULL
injury	NULL
Expression	NULL
of	NULL
each	NULL
cytokine	NULL
was	NULL
analysed	NULL
for	NULL
its	NULL
correlation	NULL
with	NULL
hepatocyte	NULL
damage	NULL
which	NULL
is	NULL
reflected	NULL
by	NULL
serum	NULL
AST/ALT	NULL
levels	NULL
.	NULL

Whereas	NULL
IFN-7	NULL
expression	NULL
appeared	NULL
to	NULL
correlate	NULL
positively	NULL
with	NULL
serum	NULL
AST	NULL
/ALT	NULL
levels	NULL
,	NULL
IL-4	NULL
expression	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
have	NULL
any	NULL
correlations	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Association	NULL
of	NULL
IFN-	NULL
?	NULL

expression	NULL
with	NULL
severe	NULL
liver	NULL
damage	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
IFN-	NULL
?	NULL

production	NULL
was	NULL
observed	NULL
in	NULL
a	NULL
majority	NULL
of	NULL
the	NULL
acute	NULL
hepatitis	NULL
B	NULL
patients	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
in	NULL
which	NULL
active	NULL
destruction	NULL
of	NULL
HBV-infected	NULL
hepatocytes	NULL
oc-curred	NULL
.	NULL

IFN-y	NULL
IL-4	NULL
IU/mL	NULL
2000	NULL
C	NULL
negative	NULL
1500	NULL
positive	NULL
1500	NULL
1000	NULL
1000	NULL
500	NULL
500	NULL
0	NULL
-	NULL
0	NULL
AST	NULL
ALT	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Relationship	NULL
between	NULL
cytokine	NULL
production	NULL
and	NULL
serum	NULL
AST/ALT	NULL
levels	NULL
.	NULL

PBMCs	NULL
from	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
were	NULL
stimulated	NULL
with	NULL
HBsAg	NULL
and	NULL
determined	NULL
for	NULL
their	NULL
IFN-7	NULL
and/or	NULL
IL-4	NULL
expression	NULL
response	NULL
by	NULL
RT-PCR	NULL
.	NULL

Serum	NULL
AST/ALT	NULL
levels	NULL
of	NULL
patients	NULL
who	NULL
showed	NULL
increased	NULL
expressions	NULL
of	NULL
IFN-y	NULL
or	NULL
IL-4	NULL
(	NULL
2	NULL
)	NULL
were	NULL
compared	NULL
to	NULL
those	NULL
of	NULL
patients	NULL
who	NULL
did	NULL
not	NULL
(	NULL
0	NULL
)	NULL
.	NULL

Cytokine	NULL
production	NULL
response	NULL
to	NULL
HBxAg	NULL
stimulation	NULL
HBxAg	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
shows	NULL
purified	NULL
GST-HBx	NULL
protein	NULL
analysed	NULL
by	NULL
western	NULL
blot	NULL
.	NULL

Since	NULL
a	NULL
large	NULL
portion	NULL
of	NULL
protein	NULL
purified	NULL
by	NULL
the	NULL
glu-tathione-sepharose	NULL
4B	NULL
affinity	NULL
chromatography	NULL
had	NULL
been	NULL
Cytokine	NULL
Profiles	NULL
Associated	NULL
with	NULL
Chronic	NULL
Hepatitis	NULL
B	NULL
74	NULL
KDa	NULL
|_	NULL
t	NULL
50	NULL
KDa	NULL
39.5	NULL
KDa	NULL
35	NULL
KDa	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Wester	NULL
blot	NULL
analysis	NULL
of	NULL
purified	NULL
GST-HBx	NULL
proteins	NULL
.	NULL

Panel	NULL
A	NULL
shows	NULL
the	NULL
result	NULL
of	NULL
westem	NULL
blot	NULL
using	NULL
anti-GST	NULL
antibody	NULL
,	NULL
and	NULL
panel	NULL
B	NULL
shows	NULL
the	NULL
result	NULL
of	NULL
western	NULL
blot	NULL
using	NULL
rabbit	NULL
anti-HBx	NULL
serum	NULL
.	NULL

Lane	NULL
1	NULL
;	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
purified	NULL
by	NULL
Glutathione	NULL
Sepharose	NULL
4B	NULL
affinity	NULL
chromatography	NULL
,	NULL
Lane	NULL
2	NULL
;	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
further	NULL
purified	NULL
by	NULL
Sephacryl	NULL
S-100	NULL
gel	NULL
filtration	NULL
to	NULL
use	NULL
as	NULL
an	NULL
antigen	NULL
.	NULL

Table	NULL
3	NULL
.	NULL

Cytokine	NULL
expression	NULL
prefiles	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
HBxAg	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
:	NULL
AST/ALT	NULL
IL-10	NULL
__	NULL
IL-4	NULL
IL-2	NULL
_	NULL
IFN-7	NULL
Patients	NULL
(	NULL
U/mL	NULL
CH	NULL
1	NULL
32/44	NULL
-	NULL
-	NULL
+	NULL
CH	NULL
2	NULL
74/143	NULL
-	NULL
-	NULL
-*	NULL
CH	NULL
3	NULL
97/152	NULL
-	NULL
+	NULL
+	NULL
+	NULL
CH	NULL
4	NULL
156/845	NULL
-	NULL
+	NULL
-	NULL
CH	NULL
5	NULL
199/220	NULL
-	NULL
-	NULL
CH6	NULL
440f1090	NULL
-	NULL
-	NULL
+	NULL
CH	NULL
7	NULL
470/1140	NULL
CH	NULL
8	NULL
533/402	NULL
-	NULL
-	NULL
CH	NULL
9	NULL
550/860	NULL
-	NULL
-	NULL
-*	NULL
CH10	NULL
590/1490	NULL
+	NULL
-	NULL
-*	NULL
+	NULL
CH11	NULL
941/150	NULL
-	NULL
CH12	NULL
1462/1500	NULL
*	NULL
Cytokine	NULL
expression	NULL
levels	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
GST-HBx	NULL
antigen	NULL
were	NULL
compared	NULL
to	NULL
levels	NULL
of	NULL
PBMCs	NULL
stimulated	NULL
with	NULL
GST	NULL
.	NULL

-	NULL
:	NULL
no	NULL
difference	NULL
,	NULL
+	NULL
:	NULL
increased	NULL
,	NULL
-*	NULL
:	NULL
not	NULL
detectable	NULL
degraded	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
the	NULL
protein	NULL
was	NULL
further	NULL
purified	NULL
by	NULL
sephacryl	NULL
S-100	NULL
gel	NULL
filtration	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

PBMCs	NULL
obtained	NULL
from	NULL
the	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
were	NULL
stimulated	NULL
with	NULL
HBxAg	NULL
and	NULL
examined	NULL
for	NULL
IL-10	NULL
,	NULL
IL-4	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IFN-7	NULL
expression	NULL
by	NULL
RT-PCR	NULL
.	NULL

Expressions	NULL
of	NULL
cytokines	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST-HBx	NULL
protein	NULL
were	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GST	NULL
protein	NULL
.	NULL

Approximately	NULL
40	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
showed	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
at	NULL
least	NULL
one	NULL
kind	NULL
of	NULL
cytokine	NULL
upon	NULL
HBxAg	NULL
stimulation	NULL
,	NULL
and	NULL
the	NULL
expression	NULL
of	NULL
each	NULL
cytokine	NULL
was	NULL
observed	NULL
in	NULL
8-16	NULL
%	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Different	NULL
from	NULL
that	NULL
IFN-	NULL
Â»	NULL
expression	NULL
upon	NULL
HBsAg	NULL
stimulation	NULL
correlated	NULL
with	NULL
relatively	NULL
high	NULL
levels	NULL
of	NULL
AST/ALT	NULL
,	NULL
there	NULL
was	NULL
no	NULL
correlation	NULL
of	NULL
any	NULL
cytokine	NULL
with	NULL
AST/ALT	NULL
levels	NULL
upon	NULL
HBxAg	NULL
stimulation	NULL
.	NULL

179	NULL
DISCUSSION	NULL
Immune	NULL
responses	NULL
are	NULL
not	NULL
very	NULL
successful	NULL
in	NULL
eliminating	NULL
HBV	NULL
from	NULL
the	NULL
body	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

Since	NULL
HBV	NULL
is	NULL
known	NULL
to	NULL
have	NULL
no	NULL
cytopathic	NULL
effect	NULL
on	NULL
the	NULL
infected	NULL
hepato-cytes	NULL
,	NULL
cell-mediated	NULL
immunity	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
hepatocellular	NULL
damage	NULL
and	NULL
HBV	NULL
clearance	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
immune	NULL
evading	NULL
mechanisms	NULL
used	NULL
by	NULL
HBV	NULL
are	NULL
largely	NULL
unknown	NULL
,	NULL
defects	NULL
in	NULL
T	NULL
cell	NULL
responses	NULL
have	NULL
been	NULL
suspected	NULL
as	NULL
a	NULL
major	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
chronic	NULL
hepatitis	NULL
B	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

Different	NULL
from	NULL
acute	NULL
self-limited	NULL
hepatitis	NULL
in	NULL
which	NULL
protective	NULL
immunity	NULL
develops	NULL
after	NULL
elimination	NULL
of	NULL
HBV	NULL
,	NULL
immune	NULL
responses	NULL
fail	NULL
to	NULL
remove	NULL
HBV-infected	NULL
hepatocytes	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

Even	NULL
more	NULL
,	NULL
barely	NULL
detectable	NULL
proliferative	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
HBsAg	NULL
has	NULL
been	NULL
consistently	NULL
reported	NULL
in	NULL
patients	NULL
with	NULL
hepatitis	NULL
B	NULL
,	NULL
whereas	NULL
humoral	NULL
and	NULL
cellular	NULL
immunity	NULL
to	NULL
HBsAg	NULL
are	NULL
easily	NULL
induced	NULL
in	NULL
vaccined	NULL
individuals	NULL
(	NULL
4	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
exact	NULL
mechanisms	NULL
of	NULL
T	NULL
cell	NULL
tolerance	NULL
to	NULL
a	NULL
HBsAg	NULL
are	NULL
unknown	NULL
,	NULL
patterns	NULL
of	NULL
cytokine	NULL
production	NULL
responding	NULL
to	NULL
HBsAg	NULL
can	NULL
provide	NULL
a	NULL
clue	NULL
to	NULL
understanding	NULL
the	NULL
pathogenic	NULL
mechanisms	NULL
of	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

To	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
immune	NULL
responses	NULL
favoring	NULL
Th2	NULL
type	NULL
cytokine	NULL
production	NULL
may	NULL
lead	NULL
to	NULL
chronic	NULL
infections	NULL
with	NULL
HBV	NULL
,	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
cytokine	NULL
profiles	NULL
associated	NULL
with	NULL
hepatitis	NULL
B	NULL
.	NULL

At	NULL
first	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
clone	NULL
HBsAg-specific	NULL
T	NULL
cells	NULL
from	NULL
PBMCs	NULL
of	NULL
hepatitis	NULL
B	NULL
patients	NULL
to	NULL
analyze	NULL
cytokine	NULL
profiles	NULL
.	NULL

Unfortunately	NULL
,	NULL
due	NULL
to	NULL
the	NULL
weak	NULL
proliferative	NULL
response	NULL
of	NULL
T	NULL
cells	NULL
obtained	NULL
from	NULL
the	NULL
hepatitis	NULL
B	NULL
patients	NULL
to	NULL
HBsAg	NULL
,	NULL
we	NULL
could	NULL
not	NULL
clone	NULL
HBs	NULL
Ag-specific	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
prepared	NULL
using	NULL
rhIL-2	NULL
.	NULL

When	NULL
these	NULL
T	NULL
cell	NULL
populations	NULL
were	NULL
tested	NULL
for	NULL
IFN-7	NULL
production	NULL
upon	NULL
HBsAg	NULL
stimulation	NULL
,	NULL
25	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B	NULL
as	NULL
well	NULL
as	NULL
80	NULL
%	NULL
of	NULL
the	NULL
patients	NULL
with	NULL
acute	NULL
hepatitis	NULL
B	NULL
showed	NULL
IFN-	NULL
Â»	NULL
production	NULL
analysed	NULL
by	NULL
ELISA	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
none	NULL
of	NULL
the	NULL
HBsAg-reactive	NULL
T	NULL
cell	NULL
populations	NULL
showed	NULL
significant	NULL
in	NULL
vitro	NULL
proliferative	NULL
responses	NULL
to	NULL
HBsAg	NULL
stimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
hardly	NULL
detectable	NULL
production	NULL
of	NULL
IL-2	NULL
by	NULL
these	NULL
T	NULL
cell	NULL
populations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
HBsAg-reactive	NULL
T	NULL
cells	NULL
have	NULL
defects	NULL
in	NULL
the	NULL
ability	NULL
to	NULL
produce	NULL
IL-2	NULL
upon	NULL
antigenic	NULL
stimulation	NULL
,	NULL
but	NULL
they	NULL
are	NULL
still	NULL
able	NULL
to	NULL
produce	NULL
other	NULL
Thl	NULL
type	NULL
cytokine	NULL
,	NULL
i.e	NULL
.	NULL

IFN-y	NULL
,	NULL
even	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
production	NULL
of	NULL
IL-4	NULL
was	NULL
not	NULL
detected	NULL
by	NULL
ELISA	NULL
.	NULL

Thl	NULL
type	NULL
pattern	NULL
of	NULL
secreted	NULL
cytokines	NULL
can	NULL
be	NULL
considered	NULL
as	NULL
an	NULL
appropriate	NULL
response	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
to	NULL
inhibit	NULL
viral	NULL
replication	NULL
and	NULL
HBV	NULL
eradication	NULL
.	NULL

Mechanisms	NULL
by	NULL
which	NULL
IEN-7	NULL
favors	NULL
the	NULL
elimination	NULL
of	NULL
HBV	NULL
may	NULL
include	NULL
enhancement	NULL
of	NULL
CTL	NULL
activation	NULL
,	NULL
direct	NULL
anti-viral	NULL
activity	NULL
,	NULL
in-creased	NULL
expression	NULL
of	NULL
MHC	NULL
class	NULL
I	NULL
molecules	NULL
on	NULL
infected	NULL
cells	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
macrophages	NULL
(	NULL
25-28	NULL
)	NULL
.	NULL

Anti-HBV	NULL
effect	NULL
of	NULL
180	NULL
HBV	NULL
was	NULL
shown	NULL
by	NULL
a	NULL
transgenic	NULL
mouse	NULL
model	NULL
showing	NULL
that	NULL
adoptive	NULL
transfer	NULL
of	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
producing	NULL
IFN-7	NULL
could	NULL
inhibit	NULL
HBV	NULL
replication	NULL
without	NULL
cell	NULL
lysis	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
an	NULL
association	NULL
of	NULL
a	NULL
predominant	NULL
Thl	NULL
cytokine	NULL
profile	NULL
of	NULL
HBcAg-specific	NULL
T	NULL
cells	NULL
with	NULL
acute	NULL
self-limited	NULL
hepatitis	NULL
B	NULL
was	NULL
reported	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Although	NULL
T	NULL
cell	NULL
proliferative	NULL
responses	NULL
to	NULL
HBsAg	NULL
are	NULL
not	NULL
as	NULL
remarkable	NULL
as	NULL
those	NULL
to	NULL
HBcAg	NULL
,	NULL
roles	NULL
of	NULL
HBsAg-reactive	NULL
T	NULL
cells	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
viral	NULL
clearance	NULL
by	NULL
several	NULL
investigators	NULL
(	NULL
19-22	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Chisari	NULL
and	NULL
his	NULL
colleagues	NULL
reported	NULL
CTL	NULL
responses	NULL
to	NULL
epitopes	NULL
of	NULL
HBsAg	NULL
in	NULL
most	NULL
patients	NULL
with	NULL
acute	NULL
hepatitis	NULL
,	NULL
while	NULL
there	NULL
were	NULL
no	NULL
such	NULL
responses	NULL
in	NULL
patients	NULL
with	NULL
chronic	NULL
hepatitis	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
results	NULL
of	NULL
our	NULL
previous	NULL
study	NULL
showed	NULL
a	NULL
correlation	NULL
of	NULL
-	NULL
production	NULL
by	NULL
HBsAg-reactive	NULL
T	NULL
cells	NULL
with	NULL
acute	NULL
self-limited	NULL
hepatitis	NULL
B	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Meanwhile	NULL
,	NULL
Barnaba	NULL
et	NULL
al	NULL
.	NULL

cloned	NULL
CD4+	NULL
HBV	NULL
envelope	NULL
antigen-reactive	NULL
T	NULL
cells	NULL
from	NULL
chronic	NULL
active	NULL
hepatitis	NULL
patients	NULL
,	NULL
and	NULL
found	NULL
that	NULL
these	NULL
T	NULL
cells	NULL
showed	NULL
signs	NULL
of	NULL
cytotoxicity	NULL
only	NULL
when	NULL
they	NULL
produced	NULL
IFN-	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
this	NULL
finding	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
production	NULL
of	NULL
IFN-Y	NULL
by	NULL
PBMCs	NULL
upon	NULL
HBsAg	NULL
stimulation	NULL
was	NULL
associated	NULL
with	NULL
higher	NULL
levels	NULL
of	NULL
hepatocyte	NULL
damage	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
Thl	NULL
type	NULL
immune	NULL
responses	NULL
in	NULL
the	NULL
development	NULL
of	NULL
cell-mediated	NULL
immunity	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
a	NULL
recent	NULL
longitudinal	NULL
study	NULL
showing	NULL
that	NULL
serum	NULL
levels	NULL
of	NULL
IL-12	NULL
,	NULL
a	NULL
cytokine	NULL
which	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
differentiation	NULL
of	NULL
T	NULL
cells	NULL
towards	NULL
Thl	NULL
type	NULL
,	NULL
was	NULL
associated	NULL
with	NULL
the	NULL
clearance	NULL
of	NULL
HBV	NULL
and	NULL
anti-H	NULL
Be	NULL
seroconversion	NULL
(	NULL
23	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
a	NULL
cytokine	NULL
balance	NULL
favoring	NULL
Th2	NULL
type	NULL
cytokine	NULL
production	NULL
such	NULL
as	NULL
IL-4	NULL
and	NULL
IL-10	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
progressive	NULL
virus	NULL
infections	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
shift	NULL
from	NULL
Thl	NULL
to	NULL
ThO	NULL
or	NULL
Th2	NULL
profiles	NULL
was	NULL
reported	NULL
in	NULL
acquired	NULL
immune	NULL
deficiency	NULL
syndrome	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

Because	NULL
clinically	NULL
overt	NULL
acute	NULL
hepatitis	NULL
B	NULL
is	NULL
generally	NULL
self-limited	NULL
,	NULL
it	NULL
is	NULL
not	NULL
easy	NULL
to	NULL
examine	NULL
cytokine	NULL
profiles	NULL
of	NULL
the	NULL
initial	NULL
immune	NULL
response	NULL
to	NULL
HBV	NULL
in	NULL
the	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
present	NULL
study	NULL
was	NULL
performed	NULL
on	NULL
chronic	NULL
hepatitis	NULL
patients	NULL
,	NULL
showing	NULL
variable	NULL
degrees	NULL
of	NULL
liver	NULL
damages	NULL
as	NULL
evidenced	NULL
by	NULL
increased	NULL
serum	NULL
AST/ALT	NULL
levels	NULL
.	NULL

Expression	NULL
of	NULL
both	NULL
Th2	NULL
type	NULL
cytokine	NULL
(	NULL
s	NULL
)	NULL
and	NULL
Thl	NULL
type	NULL
cytokine	NULL
(	NULL
s	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
in	NULL
our	NULL
study	NULL
.	NULL

This	NULL
result	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
showing	NULL
that	NULL
T	NULL
cell	NULL
populations	NULL
in	NULL
the	NULL
liver	NULL
infiltrate	NULL
secreted	NULL
both	NULL
Th1	NULL
(	NULL
IFN-	NULL
Â»	NULL
)	NULL
and	NULL
Th2	NULL
cytokines	NULL
(	NULL
IL-4	NULL
and	NULL
IL-5	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

As	NULL
the	NULL
study	NULL
was	NULL
performed	NULL
on	NULL
HBV	NULL
non-specific	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
liver	NULL
of	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
,	NULL
cytokine	NULL
profiles	NULL
of	NULL
HBV	NULL
antigen-specific	NULL
T	NULL
cells	NULL
were	NULL
not	NULL
demonstrated	NULL
.	NULL

At	NULL
the	NULL
moment	NULL
,	NULL
available	NULL
information	NULL
about	NULL
the	NULL
cytokine	NULL
production	NULL
patterns	NULL
of	NULL
HBsAg-specific	NULL
T	NULL
cells	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
is	NULL
limited	NULL
,	NULL
because	NULL
few	NULL
patients	NULL
and	NULL
clones	NULL
have	NULL
been	NULL
studied	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Results	NULL
of	NULL
the	NULL
present	NULL
study	NULL
indicate	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
Th2	NULL
type	NULL
response	NULL
M.	NULL
Lee	NULL
,	NULL
M.A	NULL
.	NULL

Lee	NULL
,	NULL
S.K	NULL
.	NULL

Lee	NULL
,	NULL
et	NULL
al	NULL
.	NULL

to	NULL
HBsAg	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
patients	NULL
and	NULL
it	NULL
appeared	NULL
to	NULL
be	NULL
combined	NULL
with	NULL
Thl	NULL
response	NULL
in	NULL
the	NULL
patients	NULL
with	NULL
more	NULL
severe	NULL
liver	NULL
damage	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicated	NULL
that	NULL
the	NULL
production	NULL
of	NULL
Th1l	NULL
cytokines	NULL
could	NULL
contribute	NULL
to	NULL
antiviral	NULL
protective	NULL
immunity	NULL
in	NULL
both	NULL
acute	NULL
and	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
Thl	NULL
response	NULL
might	NULL
be	NULL
insufficient	NULL
for	NULL
complete	NULL
removal	NULL
of	NULL
HBV	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
.	NULL

There	NULL
is	NULL
a	NULL
possibility	NULL
that	NULL
concomitant-ly	NULL
produced	NULL
Th2	NULL
type	NULL
cytokines	NULL
might	NULL
counteract	NULL
the	NULL
antiviral	NULL
effect	NULL
of	NULL
Th1	NULL
cytokines	NULL
.	NULL

However	NULL
,	NULL
we	NULL
could	NULL
not	NULL
observe	NULL
the	NULL
protective	NULL
effect	NULL
of	NULL
Th2	NULL
type	NULL
cytokine	NULL
on	NULL
the	NULL
hepatocytes	NULL
.	NULL

This	NULL
may	NULL
be	NULL
possibly	NULL
due	NULL
to	NULL
relatively	NULL
weak	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
HBsAg	NULL
compared	NULL
to	NULL
those	NULL
of	NULL
HBcAg	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Unfortunately	NULL
cytokine	NULL
profiles	NULL
of	NULL
HBcAg-reactive	NULL
T	NULL
cells	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
are	NULL
not	NULL
clear	NULL
yet	NULL
.	NULL

To	NULL
investigate	NULL
cytokine	NULL
expression	NULL
patterns	NULL
on	NULL
HBxAg	NULL
stimulation	NULL
,	NULL
PMBCs	NULL
from	NULL
patients	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B	NULL
were	NULL
stimulated	NULL
with	NULL
GST-HBx	NULL
fusion	NULL
protein	NULL
.	NULL

Although	NULL
HBx	NULL
protein	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
immunogenic	NULL
on	NULL
a	NULL
T	NULL
cell	NULL
level	NULL
in	NULL
acute	NULL
hepatitis	NULL
B	NULL
(	NULL
8	NULL
)	NULL
,	NULL
in	NULL
our	NULL
hands	NULL
proliferative	NULL
responses	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
HBxAg	NULL
were	NULL
hardly	NULL
detectable	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
by	NULL
RT-PCR	NULL
approximately	NULL
40	NULL
%	NULL
of	NULL
patients	NULL
showed	NULL
cytokine	NULL
expression	NULL
response	NULL
upon	NULL
HBxAg	NULL
stimulation	NULL
analysed	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
relationship	NULL
between	NULL
cytokine	NULL
profiles	NULL
and	NULL
hepatocyte	NULL
damage	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
Thl	NULL
responses	NULL
to	NULL
HBxAg	NULL
seems	NULL
to	NULL
be	NULL
weaker	NULL
than	NULL
those	NULL
to	NULL
HBsAg	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
could	NULL
not	NULL
show	NULL
that	NULL
a	NULL
predominant	NULL
production	NULL
of	NULL
Th2	NULL
type	NULL
cytokines	NULL
upon	NULL
HBsAg	NULL
or	NULL
HBxAg	NULL
antigen	NULL
stimulation	NULL
may	NULL
cause	NULL
persistent	NULL
infection	NULL
of	NULL
HBV	NULL
.	NULL

However	NULL
,	NULL
lacking	NULL
data	NULL
from	NULL
other	NULL
investigators	NULL
on	NULL
cytokine	NULL
profiles	NULL
of	NULL
HBV-specific	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
roles	NULL
of	NULL
Th2	NULL
type	NULL
responses	NULL
in	NULL
viral	NULL
persistency	NULL
should	NULL
be	NULL
further	NULL
studied	NULL
.	NULL

As	NULL
our	NULL
data	NULL
consistently	NULL
indicated	NULL
,	NULL
the	NULL
production	NULL
of	NULL
IFN-7	NULL
by	NULL
HBsAg-reactive	NULL
cells	NULL
was	NULL
associated	NULL
with	NULL
HBV	NULL
clearance	NULL
.	NULL

Recently	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
IL-12	NULL
could	NULL
induce	NULL
proliferation	NULL
and	NULL
IFN-7	NULL
-	NULL
production	NULL
of	NULL
HBsAg-stimulated	NULL
PBMCs	NULL
in	NULL
vitro	NULL
(	NULL
29	NULL
)	NULL
.	NULL

If	NULL
we	NULL
can	NULL
find	NULL
a	NULL
way	NULL
to	NULL
induce	NULL
a	NULL
strong	NULL
Thl	NULL
type	NULL
immune	NULL
response	NULL
to	NULL
HBsAg	NULL
,	NULL
successful	NULL
resolution	NULL
of	NULL
HBV	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
can	NULL
be	NULL
possible	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Chisari	NULL
FV	NULL
.	NULL

Hepatitis	NULL
B	NULL
virus	NULL
immunopathogenesis	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
1995	NULL
;	NULL
13	NULL
:	NULL
29-60	NULL
.	NULL

2	NULL
.	NULL

Ishikawa	NULL
T	NULL
,	NULL
Kakumu	NULL
S	NULL
,	NULL
Yoshioka	NULL
K	NULL
,	NULL
Wakita	NULL
T	NULL
,	NULL
Takayanagi	NULL
M	NULL
,	NULL
Olido	NULL
,	NULL
E.	NULL
:	NULL
Immune	NULL
response	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
to	NULL
antigenic	NULL
determinants	NULL
within	NULL
hepatitis	NULL
B	NULL
core	NULL
antigen	NULL
in	NULL
HB	NULL
virus-infected	NULL
man	NULL
.	NULL

Liver	NULL
1992	NULL
;	NULL
12	NULL
:	NULL
100-5	NULL
.	NULL

3	NULL
.	NULL

Marinos	NULL
G	NULL
,	NULL
Torre	NULL
F	NULL
,	NULL
Chokshi	NULL
S	NULL
,	NULL
Hussain	NULL
M	NULL
,	NULL
Clarke	NULL
BE	NULL
,	NULL
Rowlands	NULL
DJ	NULL
,	NULL
Eddleston	NULL
ALWE	NULL
,	NULL
Naoumov	NULL
NV	NULL
,	NULL
Williams	NULL
R.	NULL
Induction	NULL
of	NULL
T-helper	NULL
cell	NULL
response	NULL
to	NULL
hepatitis	NULL
B	NULL
core	NULL
antigen	NULL
in	NULL
chronic	NULL
hepatitis	NULL
Cytokine	NULL
Profiles	NULL
Associated	NULL
with	NULL
Chronic	NULL
Hepatitis	NULL
B	NULL
B	NULL
:	NULL
a	NULL
major	NULL
factor	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
host	NULL
immune	NULL
response	NULL
to	NULL
the	NULL
hepatitis	NULL
B	NULL
virus	NULL
.	NULL

Hepatology	NULL
1995	NULL
;	NULL
22	NULL
:	NULL
1040-9	NULL
.	NULL

4	NULL
.	NULL

Ferrari	NULL
C	NULL
,	NULL
Penna	NULL
A	NULL
,	NULL
Bertolett	NULL
A	NULL
,	NULL
Valli	NULL
A	NULL
,	NULL
Antoni	NULL
AD	NULL
,	NULL
Giuberti	NULL
T	NULL
,	NULL
Cavalli	NULL
A	NULL
,	NULL
Petit	NULL
M-A	NULL
,	NULL
Fiaccadori	NULL
F.	NULL
Cellular	NULL
immune	NULL
response	NULL
to	NULL
hepatitis	NULL
B	NULL
virus-encoded	NULL
antigens	NULL
in	NULL
acute	NULL
and	NULL
chronic	NULL
hepatitis	NULL
B	NULL
virus	NULL
infection	NULL
.	NULL

J	NULL
Immunol	NULL
1990	NULL
;	NULL
145	NULL
:	NULL
3442-9	NULL
.	NULL

5	NULL
.	NULL

Marinos	NULL
G	NULL
,	NULL
Torre	NULL
F	NULL
,	NULL
Chokshi	NULL
S	NULL
,	NULL
Hussain	NULL
M	NULL
,	NULL
Clarke	NULL
BE	NULL
,	NULL
Rowlands	NULL
DJ	NULL
,	NULL
Eddleston	NULL
ALWE	NULL
,	NULL
Naoumov	NULL
NV	NULL
,	NULL
Williams	NULL
R.	NULL
Induction	NULL
of	NULL
T-helper	NULL
cell	NULL
response	NULL
to	NULL
hepatitis	NULL
B	NULL
core	NULL
antigen	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
:	NULL
a	NULL
major	NULL
factor	NULL
in	NULL
activation	NULL
of	NULL
the	NULL
host	NULL
immune	NULL
response	NULL
to	NULL
the	NULL
hepatitis	NULL
B	NULL
virus	NULL
.	NULL

Hepatology	NULL
1995	NULL
;	NULL
22	NULL
:	NULL
1040-9	NULL
.	NULL

6	NULL
.	NULL

Lohr	NULL
HF	NULL
,	NULL
Weber	NULL
W	NULL
,	NULL
Schlaak	NULL
J	NULL
,	NULL
Goergen	NULL
B	NULL
,	NULL
Buschenfelde	NULL
K-HMLZ	NULL
,	NULL
Gerken	NULL
G.	NULL
Proliferative	NULL
response	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
hepatitis	NULL
B	NULL
virus	NULL
clearance	NULL
in	NULL
chronic	NULL
hepatitis	NULL
with	NULL
or	NULL
without	NULL
hepatitis	NULL
B	NULL
e-minus	NULL
hepatitis	NULL
B	NULL
virus	NULL
mutants	NULL
.	NULL

Hepatology1995	NULL
;	NULL
2	NULL
:	NULL
61-8	NULL
.	NULL

7	NULL
.	NULL

Jung	NULL
M-C	NULL
,	NULL
Diepolder	NULL
HM	NULL
,	NULL
Pape	NULL
GR	NULL
.	NULL

T	NULL
cell	NULL
recognition	NULL
of	NULL
hepatitis	NULL
B	NULL
and	NULL
C	NULL
viral	NULL
antigens	NULL
.	NULL

Fur	NULL
J	NULL
Clin	NULL
Invest	NULL
1994	NULL
;	NULL
24	NULL
:	NULL
641-50	NULL
.	NULL

8	NULL
.	NULL

Jung	NULL
M-C	NULL
,	NULL
Stemler	NULL
M	NULL
,	NULL
Weimer	NULL
T	NULL
,	NULL
Spengler	NULL
U	NULL
,	NULL
Dohrmann	NULL
J	NULL
,	NULL
Hoff-mann	NULL
R	NULL
,	NULL
Eichenlaub	NULL
D	NULL
,	NULL
Eisenburg	NULL
J	NULL
,	NULL
Paumgartner	NULL
G	NULL
,	NULL
Riethmuller	NULL
G	NULL
,	NULL
Will	NULL
H	NULL
,	NULL
Pape	NULL
GR	NULL
.	NULL

Immune	NULL
responses	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
to	NULL
HBx-antigen	NULL
of	NULL
hepatitis	NULL
B	NULL
virus	NULL
.	NULL

Hepatology	NULL
1991	NULL
;	NULL
13	NULL
:	NULL
637-43	NULL
.	NULL

9	NULL
.	NULL

Paul	NULL
WE	NULL
,	NULL
Seder	NULL
RA	NULL
.	NULL

Lymphocyte	NULL
responses	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
1994	NULL
;	NULL
76	NULL
:	NULL
241-51	NULL
.	NULL

10	NULL
.	NULL

Sher	NULL
A	NULL
,	NULL
Coffman	NULL
RL	NULL
.	NULL

Regulation	NULL
of	NULL
immunity	NULL
to	NULL
parasites	NULL
by	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell-derived	NULL
cytokines	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
1992	NULL
;	NULL
10	NULL
:	NULL
385-409	NULL
.	NULL

11	NULL
.	NULL

Yamamura	NULL
M	NULL
,	NULL
Uyemura	NULL
K	NULL
,	NULL
Deans	NULL
RJ	NULL
,	NULL
Weinberg	NULL
K	NULL
,	NULL
Rea	NULL
TH	NULL
,	NULL
Bloom	NULL
BR	NULL
,	NULL
Modlin	NULL
RL	NULL
.	NULL

Defining	NULL
protective	NULL
response	NULL
to	NULL
pathogens	NULL
:	NULL
cytokine	NULL
profiles	NULL
in	NULL
leprosy	NULL
lesions	NULL
.	NULL

Science	NULL
1991	NULL
;	NULL
254	NULL
:	NULL
277-9	NULL
.	NULL

12	NULL
.	NULL

Carding	NULL
SR	NULL
,	NULL
Allan	NULL
W	NULL
,	NULL
McMickle	NULL
A	NULL
,	NULL
Doherty	NULL
PC	NULL
.	NULL

Activation	NULL
of	NULL
cytokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
during	NULL
primary	NULL
and	NULL
secondary	NULL
murine	NULL
influenza	NULL
pneumonia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1993	NULL
;	NULL
177	NULL
:	NULL
475-82	NULL
.	NULL

13	NULL
.	NULL

Ramsay	NULL
AJ	NULL
,	NULL
Ruby	NULL
J	NULL
,	NULL
Ramshaw	NULL
IA	NULL
.	NULL

A	NULL
case	NULL
for	NULL
cytokines	NULL
as	NULL
effector	NULL
molecules	NULL
in	NULL
the	NULL
resolution	NULL
of	NULL
virus	NULL
infection	NULL
.	NULL

Immunol	NULL
Today	NULL
1993	NULL
;	NULL
14	NULL
:	NULL
155-7	NULL
.	NULL

14	NULL
.	NULL

Maggi	NULL
E	NULL
,	NULL
Mazzetti	NULL
M	NULL
,	NULL
Ravina	NULL
A	NULL
,	NULL
Annunziato	NULL
F	NULL
,	NULL
De	NULL
Carli	NULL
M	NULL
,	NULL
Piccin-ni	NULL
MP	NULL
,	NULL
Manetti	NULL
R.	NULL
Ability	NULL
of	NULL
HIV	NULL
to	NULL
promote	NULL
a	NULL
Th1	NULL
to	NULL
ThO	NULL
shift	NULL
and	NULL
to	NULL
replicate	NULL
preferentially	NULL
in	NULL
ThZ	NULL
and	NULL
ThO	NULL
cells	NULL
.	NULL

Science	NULL
1994	NULL
;	NULL
265	NULL
:	NULL
244-8	NULL
.	NULL

15	NULL
.	NULL

Clerici	NULL
M	NULL
,	NULL
Hakin	NULL
FT	NULL
,	NULL
Venzon	NULL
DJ	NULL
,	NULL
Blatt	NULL
S	NULL
,	NULL
Hendrix	NULL
CW	NULL
,	NULL
Wynn	NULL
TW	NULL
,	NULL
Shearer	NULL
GM	NULL
.	NULL

Changes	NULL
in	NULL
interleukin-2	NULL
and	NULL
interleukin-4	NULL
production	NULL
in	NULL
asymptomatic	NULL
,	NULL
human	NULL
immunodeficiency	NULL
virus-seropositive	NULL
indi-viduals	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
1993	NULL
;	NULL
91	NULL
:	NULL
759-65	NULL
.	NULL

16	NULL
.	NULL

Guidotti	NULL
LG	NULL
,	NULL
Ando	NULL
K	NULL
,	NULL
Hobbs	NULL
MV	NULL
,	NULL
Ishikava	NULL
T	NULL
,	NULL
Runkel	NULL
L	NULL
,	NULL
Schreiber	NULL
RD	NULL
,	NULL
Chisari	NULL
FV	NULL
.	NULL

Cytotoxic	NULL
T	NULL
lymphocyte	NULL
inhibit	NULL
hepatitis	NULL
B	NULL
virus	NULL
gene	NULL
expression	NULL
by	NULL
a	NULL
noncytolytic	NULL
mechanism	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sei	NULL
USA	NULL
1994	NULL
;	NULL
91	NULL
:	NULL
3764-8	NULL
.	NULL

17	NULL
.	NULL

Penna	NULL
A	NULL
,	NULL
Del	NULL
Prete	NULL
G	NULL
,	NULL
Cavalli	NULL
A	NULL
,	NULL
Bertoletti	NULL
A	NULL
,	NULL
D	NULL
'	NULL
Elios	NULL
MM	NULL
,	NULL
Sor-rentino	NULL
R	NULL
,	NULL
D'Amato	NULL
M	NULL
,	NULL
Boni	NULL
C	NULL
,	NULL
Pilli	NULL
M	NULL
,	NULL
Fiaceadori	NULL
F	NULL
,	NULL
Ferrari	NULL
C.	NULL
181	NULL
Predominant	NULL
T-helper	NULL
1	NULL
cytokine	NULL
profile	NULL
of	NULL
hepatitis	NULL
B	NULL
virus	NULL
nucleo-capsid-specific	NULL
T	NULL
cells	NULL
in	NULL
acute	NULL
self-limited	NULL
hepatitis	NULL
B.	NULL
Hepatology	NULL
1997	NULL
;	NULL
25	NULL
:	NULL
1022-7	NULL
.	NULL

18	NULL
.	NULL

Lee	NULL
M	NULL
,	NULL
Lee	NULL
SK	NULL
,	NULL
Park	NULL
S	NULL
,	NULL
Cho	NULL
S-W	NULL
,	NULL
Youn	NULL
JK	NULL
,	NULL
Kim	NULL
HIL	NULL
.	NULL

Production	NULL
of	NULL
IFN-y	NULL
by	NULL
HBsAg-reactive	NULL
T	NULL
cells	NULL
correlates	NULL
with	NULL
viral	NULL
clearance	NULL
in	NULL
HBV	NULL
infection	NULL
.	NULL

J	NULL
Korean	NULL
Soc	NULL
Microbiol	NULL
1997	NULL
;	NULL
32	NULL
:	NULL
667-73	NULL
.	NULL

19	NULL
.	NULL

Shu	NULL
P-Y	NULL
,	NULL
Lin	NULL
M-Y	NULL
,	NULL
Chang	NULL
C	NULL
,	NULL
Hwang	NULL
L-H	NULL
,	NULL
Huang	NULL
J-H	NULL
,	NULL
Chang	NULL
T-H	NULL
,	NULL
Hu	NULL
CP	NULL
.	NULL

Presence	NULL
of	NULL
hepatitis	NULL
B	NULL
surface	NULL
antigen	NULL
(	NULL
HEsAg	NULL
)	NULL
-specific	NULL
cytotoxic	NULL
T	NULL
cells	NULL
asymptomatic	NULL
HBsAg	NULL
carriers	NULL
.	NULL

J	NULL
Infect	NULL
Dis	NULL
1994	NULL
;	NULL
169	NULL
:	NULL
633-7	NULL
.	NULL

20	NULL
.	NULL

Baaba	NULL
V	NULL
,	NULL
Franco	NULL
A	NULL
,	NULL
Paroli	NULL
M	NULL
,	NULL
Benvenuto	NULL
R	NULL
,	NULL
Petrillo	NULL
GD	NULL
,	NULL
Burgio	NULL
VL	NULL
,	NULL
Santilio	NULL
I	NULL
,	NULL
Balsano	NULL
C	NULL
,	NULL
Bonavita	NULL
MS	NULL
,	NULL
Cappelli	NULL
G	NULL
,	NULL
Colizzi	NULL
V	NULL
,	NULL
Cutrona	NULL
G	NULL
,	NULL
Ferrarini	NULL
M.	NULL
Selective	NULL
expansion	NULL
of	NULL
cytotoxic	NULL
T	NULL
lymphocytes	NULL
with	NULL
a	NULL
CD4*CD356Â®	NULL
surface	NULL
phenotype	NULL
and	NULL
a	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
profile	NULL
of	NULL
cytokine	NULL
secretion	NULL
in	NULL
the	NULL
liver	NULL
of	NULL
patients	NULL
chronically	NULL
infected	NULL
with	NULL
hepatitis	NULL
B	NULL
virus	NULL
.	NULL

J	NULL
Immunol	NULL
1994	NULL
;	NULL
152	NULL
:	NULL
3074-87.	NULL
.	NULL

Penna	NULL
A	NULL
,	NULL
Fowler	NULL
P	NULL
,	NULL
Bertoletti	NULL
A	NULL
,	NULL
Guilhot	NULL
S	NULL
,	NULL
Moss	NULL
B	NULL
,	NULL
Margolskee	NULL
R	NULL
F	NULL
,	NULL
Cavalli	NULL
A	NULL
,	NULL
Valli	NULL
A	NULL
,	NULL
Fiaccadoni	NULL
F	NULL
,	NULL
Chisari	NULL
FV	NULL
,	NULL
Ferran	NULL
C.	NULL
Hepatitis	NULL
B	NULL
virus	NULL
(	NULL
HBV	NULL
)	NULL
-specific	NULL
cytotoxic	NULL
T-cell	NULL
(	NULL
CTL	NULL
)	NULL
response	NULL
in	NULL
humans	NULL
:	NULL
characterization	NULL
of	NULL
HLA	NULL
class	NULL
CTLs	NULL
that	NULL
recognize	NULL
endogenously	NULL
synthesized	NULL
HBV	NULL
envelope	NULL
antigens	NULL
.	NULL

J	NULL
Virol	NULL
1991	NULL
;	NULL
66	NULL
:	NULL
1193-8	NULL
.	NULL

22	NULL
.	NULL

Nayersina	NULL
R	NULL
,	NULL
Fowler	NULL
P	NULL
,	NULL
Guilhot	NULL
S	NULL
,	NULL
Missale	NULL
G	NULL
,	NULL
Cerny	NULL
A	NULL
,	NULL
Schlicht	NULL
HJ	NULL
,	NULL
Vitiello	NULL
A	NULL
,	NULL
Chesnut	NULL
R	NULL
,	NULL
Person	NULL
JL	NULL
,	NULL
Redeker	NULL
AG	NULL
,	NULL
Chisari	NULL
FV	NULL
.	NULL

HLA	NULL
AZ	NULL
restricted	NULL
cytotoxic	NULL
T	NULL
lymphocyte	NULL
responses	NULL
to	NULL
multiple	NULL
hepatitis	NULL
B	NULL
surface	NULL
antigen	NULL
epitopes	NULL
during	NULL
hepatitis	NULL
B	NULL
virus	NULL
infection	NULL
.	NULL

J	NULL
Immunol	NULL
1993	NULL
;	NULL
150	NULL
:	NULL
4659-71	NULL
.	NULL

23	NULL
.	NULL

Rossol	NULL
S	NULL
,	NULL
Marinos	NULL
G	NULL
,	NULL
Carucei	NULL
P	NULL
,	NULL
Singer	NULL
MV	NULL
,	NULL
William	NULL
R	NULL
,	NULL
Naoumov	NULL
NV	NULL
.	NULL

Interleukin-12	NULL
induction	NULL
of	NULL
Th1	NULL
cytokines	NULL
is	NULL
important	NULL
for	NULL
viral	NULL
clearance	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B.	NULL
J	NULL
Clin	NULL
Invest	NULL
1997	NULL
;	NULL
99	NULL
:	NULL
3025-33	NULL
.	NULL

24	NULL
.	NULL

Bertoletti	NULL
A	NULL
,	NULL
D	NULL
'	NULL
Elios	NULL
MM	NULL
,	NULL
Boni	NULL
C	NULL
,	NULL
De	NULL
Carli	NULL
M	NULL
,	NULL
Zignego	NULL
AL	NULL
,	NULL
Durazzo	NULL
M	NULL
,	NULL
Missale	NULL
G	NULL
,	NULL
Penna	NULL
A	NULL
,	NULL
Fiaceador	NULL
F	NULL
,	NULL
Del	NULL
Prete	NULL
G	NULL
,	NULL
Ferran	NULL
C.	NULL
Different	NULL
cytokine	NULL
profiles	NULL
of	NULL
intrahepatic	NULL
T	NULL
cells	NULL
in	NULL
chronic	NULL
hepatitis	NULL
B	NULL
and	NULL
hepatitis	NULL
C	NULL
virus	NULL
infections	NULL
.	NULL

Gastroenterology	NULL
1997	NULL
;	NULL
112	NULL
;	NULL
193-9	NULL
.	NULL

25	NULL
.	NULL

Toyonaga	NULL
T	NULL
,	NULL
Hino	NULL
O	NULL
,	NULL
Sugai	NULL
S	NULL
,	NULL
Wakasugi	NULL
S	NULL
,	NULL
Ab	NULL
,	NULL
K	NULL
,	NULL
Shichiri	NULL
M	NULL
,	NULL
Yamamura	NULL
K-I	NULL
.	NULL

Chronic	NULL
active	NULL
hepatitis	NULL
in	NULL
transgenic	NULL
mice	NULL
expressing	NULL
interferon-	NULL
Â»	NULL
in	NULL
the	NULL
liver	NULL
.	NULL

Proc	NULL
Nat	NULL
!	NULL

Acad	NULL
Sci	NULL
USA	NULL
1994	NULL
;	NULL
91	NULL
:	NULL
614-8	NULL
.	NULL

26	NULL
.	NULL

Paul	NULL
E	NULL
,	NULL
Seder	NULL
RA	NULL
.	NULL

Lymphocyte	NULL
responses	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
1994	NULL
;	NULL
76	NULL
:	NULL
241-51	NULL
.	NULL

27	NULL
.	NULL

Peters	NULL
M.	NULL
Actions	NULL
of	NULL
cytokines	NULL
on	NULL
the	NULL
immune	NULL
response	NULL
and	NULL
viral	NULL
interactions	NULL
:	NULL
an	NULL
overview	NULL
.	NULL

Hepatology	NULL
1996	NULL
;	NULL
23	NULL
:	NULL
909-16	NULL
.	NULL

28	NULL
.	NULL

Ando	NULL
K	NULL
,	NULL
Moriyama	NULL
T	NULL
,	NULL
Guidotti	NULL
LG	NULL
,	NULL
Wirth	NULL
S	NULL
,	NULL
Schreiber	NULL
RD	NULL
,	NULL
Schlicht	NULL
HJ	NULL
,	NULL
Huang	NULL
SN	NULL
.	NULL

Mechanisms	NULL
of	NULL
class	NULL
I	NULL
restricted	NULL
immunopathol-ogy	NULL
:	NULL
a	NULL
transgenic	NULL
mouse	NULL
model	NULL
of	NULL
fulminant	NULL
hepatitis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1993	NULL
;	NULL
178	NULL
:	NULL
1541-54	NULL
.	NULL

29	NULL
.	NULL

Vingerhoets	NULL
J	NULL
,	NULL
Michielsen	NULL
P	NULL
,	NULL
Vanham	NULL
G	NULL
,	NULL
Bosmans	NULL
E	NULL
,	NULL
Pauly	NULL
W	NULL
,	NULL
Ramon	NULL
A	NULL
,	NULL
Pelekmans	NULL
P	NULL
,	NULL
Kestens	NULL
L	NULL
,	NULL
Leroux-Roels	NULL
G.	NULL
HBV-specific	NULL
lymphoproliferative	NULL
and	NULL
cytokine	NULL
responses	NULL
in	NULL
patients	NULL
with	NULL
chronic	NULL
hepatitis	NULL
B.	NULL
J	NULL
Hepatol	NULL
1998	NULL
;	NULL
28	NULL
:	NULL
8-16	NULL
.	NULL

2	NULL
w	NULL

